Ximelagatran--promises and concerns
- PMID: 15701916
- DOI: 10.1001/jama.293.6.736
Ximelagatran--promises and concerns
Comment in
-
Safety of ximelagatran.JAMA. 2005 Jun 15;293(23):2859; author reply 2859-60. doi: 10.1001/jama.293.23.2859-a. JAMA. 2005. PMID: 15956625 No abstract available.
Comment on
-
Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.JAMA. 2005 Feb 9;293(6):681-9. doi: 10.1001/jama.293.6.681. JAMA. 2005. PMID: 15701909 Clinical Trial.
-
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial.JAMA. 2005 Feb 9;293(6):690-8. doi: 10.1001/jama.293.6.690. JAMA. 2005. PMID: 15701910 Clinical Trial.
-
Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.JAMA. 2005 Feb 9;293(6):699-706. doi: 10.1001/jama.293.6.699. JAMA. 2005. PMID: 15701911
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
